Bide Pharmatech Co., Ltd. engages in the research, development, production, and sale of drug molecule building blocks and scientific reagents in China. Its prod...
Exploring Undiscovered Gems in Asia This September 2025
Eight biopharmaceutical and CXO companies on the Sci-Tech Innovation Board gathered for a performance briefing, breaking through key technological bottlenecks became the focus of interaction
Some shareholders of Bide Pharmaceuticals plan to reduce their holdings by no more than 1%
Bide Pharmaceuticals shareholders Zhoushan Xinxie, Ningbo Landan, and their concerted parties plan to reduce their holdings by no more than 2.86% of shares
A-share innovative drug concept stocks rose again, with Chemexpress, HitGen, and Medicilon increasing by over 10%, while Bide and WuXi AppTec also followed suit
The CRO index's intraday increase expanded to 3%, Medicilon hit the limit up, JOINN, Bide, Sun-Novo, and INNOSTAR followed suit